Bionime Corporation Sustainability Profile
Bionime Corporation, a leading innovator in the medical device industry, is headquartered in Taiwan (TW) and operates extensively across Asia and beyond. Founded in 2003, the company has established itself as a key player in the development of advanced blood glucose monitoring systems, catering primarily to individuals with diabetes. Bionime's flagship products, including the renowned GM series of glucose meters, are distinguished by their accuracy, user-friendly design, and rapid testing capabilities. These features have positioned Bionime as a trusted brand among healthcare professionals and patients alike. With a commitment to enhancing diabetes management, Bionime continues to achieve significant milestones, solidifying its reputation in the global market for reliable and innovative healthcare solutions.
DitchCarbon Score
How does Bionime Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bionime Corporation's score of 22 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bionime Corporation's reported carbon emissions
Bionime Corporation, headquartered in Taiwan (TW), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. Consequently, there are no recorded Scope 1, 2, or 3 emissions to analyse. Additionally, the company has not established any documented reduction targets or climate pledges, which limits the available information on their climate commitments. As Bionime Corporation does not inherit emissions data from a parent company, all information regarding their climate initiatives is self-contained. Without specific targets or achievements, it is unclear how the company plans to address its carbon footprint or contribute to broader climate goals. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate climate impact. However, Bionime Corporation's current lack of emissions data and reduction commitments suggests an opportunity for future engagement in climate action.
How Carbon Intensive is Bionime Corporation's Industry?
How Carbon Intensive is Bionime Corporation's Location?
Bionime Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bionime Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
